Dexlansoprazole Capsule, Delayed Release Pellets
Product Images NDC 0378-2085

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 0378-2085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dexlansoprazole Structural Formula (Image 01)

Dexlansoprazole Structural Formula (Image 01)
FDA Label Image

Figure 1: Mean Plasma Dexlansoprazole Concentration – Time Profile Following Oral Administration Of 30 Or 60 mg Dexlansoprazole Once Daily For 5 Days In Healthy Adult Subjects (Image 02)

Figure 1: Mean Plasma Dexlansoprazole Concentration – Time Profile Following Oral Administration Of 30 Or 60 mg Dexlansoprazole Once Daily For 5 Days In Healthy Adult Subjects (Image 02)
FDA Label Image

Dexlansoprazole Delayed-release Capsules 30 mg Bottle Label (Image 03)

Dexlansoprazole Delayed-release Capsules 30 mg Bottle Label (Image 03)
FDA Label Image

Dexlansoprazole Delayed-release Capsules 60 mg Bottle Label (Image 04)

Dexlansoprazole Delayed-release Capsules 60 mg Bottle Label (Image 04)